Selective eosinophil adhesion to fibroblast via IFN-γ-induced galectin-9

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5912-5918

  Asakura, Hirofumi ^a   Kashio, Yumiko ^a   Nakamura, Kazuhiro ^a   Seki, Masako ^a   Dai, Shuyan ^a   Shirato, Yukako ^a   Abedin, Mohammad J ^a   Yoshida, Naoko ^a   Nishi, Nozomu ^a   Imaizumi, Tadaatsu ^a   Saita, Naoki ^a   Toyama, Yoshihiro ^a   Takashima, Hitoshi ^a   Nakamura, Takanori ^a   Ohkawa, Motoomi ^a   Hirashima, Mitsuomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ECALECTIN; GALECTIN; GALECTIN 9 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 4; LACTOSE; MEMBRANE PROTEIN; MESSENGER RNA; POLYCLONAL ANTIBODY; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; EOSINOPHIL; FIBROBLAST; FIBROBLAST CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; TH2 CELL; UPREGULATION; WESTERN BLOTTING;

EID: 0037111524     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5912     Document Type: Article

References (43)

1. Perillo, N. L., M. E. Marcus, and L. G. Baum. 1998. Galectins. Versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76:402.
2. Leffler, H. 1997. Introduction to galectins. Trends. Glycosci. Glycobiotechnol. 9:9.
3. Barondes, S. H., V. Castronovo, D. N. W. Cooper, R. D. Cummings, J. Hirabayashi, C. Hughes, K.-I. Kasai, H. Leffler, and F.-T. Liu. 1994. Galectins, a family of animal β-galactoside-binding lectins. Cell 76:597.
4. Rabinovich, G. A. 1999. Galectins: An evolutionarily conserved family of animal lectins with multifunctional properties: A trip from the gene to clinical therapy. Cell Death. Differ. 6:711.
5. Barondes, S. H., D. N. W. Cooper, M. A. Gitt, and H. Leffler. 1994. Galectins: Structure and function of a large family of animal lectins. J. Biol. Chem. 269: 20807.
6. Hirashima. M. 1999. Ecalectin as a T cell-derived eosinophil chemoattractant. Int. Arch. Allergy. Immunol. 120(Suppl. 1):7.
7. Liu, F.-T. 2000. Galectins: A new family of regulators of inflammation. Clin. Immunol 97:79.
8. Tureci, O., H. Schmitt, N. Fadle, M. Pfreundschuh, and U. Sahin. 1997. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J. Biol. Chem. 272:6416.
9. Hirashima, M. 2000. Ecalectin/galectin-9, a novel eosinophil chemoattractant: Its function and production. Int. Arch. Allergy. Immunol. 122(Suppl. 1):6.
10. Chabot. S., Y. Kashio, M. Seki, Y. Shirato, K. Nakamura, N. Nishi, T. Nakamura, R. Matsumoto, and M. Hirashima. 2002. Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12:111.
11. Sato, M., N. Nishi, H. Shoji, M. Seki, T. Hashidate, J. Hirabayashi, K. Kasai, Y. Hata, S. Suzuki, M. Hirashima, et al. 2002. Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology 12:191.
12. Matsumoto, R., H. Matsumoto, M. Seki, M. Hata, Y. Asano, S. Kanegasaki, R. L. Stevens, and M. Hirashima. 1998. Human ecalectin, a variant of human galectin-9 is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 273:16976.
13. Matsushita, N., N. Nishi, M. Seki, R. Matsumoto, I. Kuwabara, F.-T. Liu, Y. Hata, T. Nakamura, and M. Hirashima. 2000. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J. Biol. Chem. 275:8355.
14. Weller, P. F. 1997. Human eosinophils. J. Allergy. Clin. Immunol. 100:283.
15. Pincus, S. H., K. S. Ramesh, and D. J. Wyler. 1987. Eosinophils stimulate fibroblast DNA synthesis. Blood 70:572.
16. Birkland, T. P., M. D. Cheavens, and S. H. Pincus. 1994. Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch. Dermatol. Res. 286:312.
17. Shock, A., K. F. Rabe, G. Dent, R. C. Chambers, A. J. Gray, K. F. Chung, P. J. Barnes, and G. J. Laurent. 1991. Eosinophils adhere to and stimulate replication of lung fibroblasts "in vitro." Clin. Exp. Immunol. 86:185.
18. Inohara, H., S. Akahani, and A. Raz. 1998. Galectin-3 stimulates cell proliferation. Exp. Cell Res. 245:294.
19. Goldring, K., G. E. Jones, C. A. Sewry, and D. J. Watt. 2002. The muscle-specific marker desmin is expressed in a proportion of human dermal fibroblasts after their exposure to galectin-1. Neuromuscul. Disord. 12:183.
20. Hirashima, M., M. Ueno, S. Higuchi, T. Matsumoto, K. Sakata, R. Matsumoto, and M. Adachi. 1992. Establishment of a human T-cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity on eosinophils. Lymphokine Cytokine Res. 11:331.
21. Young, H. A., and K. J. Hardy. 1995. Role of interferon in immune cell regulation. J. Leukocyte Biol. 58:373.
22. De Maeyer, E., and J. De Maeyer-Guingard. 1992. Interferon-γ. Curr. Opin. Immunol. 4:321.
23. Rosenbloom, J., G. Feldman, B. Freundlich, and S. A. Jimenez. 1984. Transcriptional control of human diploid fibroblast collagen synthesis by γ-interferon. Biochem. Biophys. Res. Commun. 123:365.
24. Elias, J. A., S. A. Jimenez, and B. Freundlich. 1987. Recombinant γ, α, and β interferon regulation of human lung fibroblast proliferation. Am. Rev. Respir. Dis. 135:62.
25. Zhang, K., M. Gharaee-Kermani, B. McGarry, D. Remick, and S. H. Phan. 1997. TNF-α-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J. Immunol. 158:954.
26. Peterson, M. W., M. Monick, and G. W. Hunninghake. 1987. Prognostic role of eosinophils in pulmonary fibrosis. Chest. 92:51.
27. Hallgren, R., L. Bjermer, R. Lundgren, and P. Venge. 1989. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: Signs of eosinophil activation in the lung are related to impaired lung function. Am. Rev. Respir. Dis. 139:373.
28. Takafuji, S., Y. Miyakuni, T. Nakagawa, S. Shoji, S. Murata, K. Yamamoto, and K. Ito. 2000. Effects of human lung fibroblasts on eosinophil degranulation. Allergy 55:1170.
29. Vancheri, C., J. Gauldie, J. Bienenstock, G. Cox, R. Scicchitano, A. Stanisz, and M. Jordana. 1989. Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am. J. Respir. Cell Mol. Biol. 1:289.
30. Solomon, A., R. Shmilowich, D. Shasha, J. Frucht-Pery, J. Pe'er, S. Bonini, and F. Levi-Schaffer. 2000. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro. Invest. Ophthalmol. Vis. Sci. 41:1038.
31. Matsumoto, R., M. Hirashima, H. Kita, and G. J. Gleich. 2002. Biological activities of ecalectin: A novel eosinophil-activating factor. J. Immunol. 168:1961.
32. Saita, N., E. Goto, T. Yamamoto, I. Cho, K. Tsumori, H. Kohrogi, K. Maruo, T. Ono, M. Takeya, Y. Kashio, et al. 2002. Association of galectin-9 with eosinophil apoptosis. Int. Arch. Allergy. Immunol. 128:42.
33. Eickelberg, O., A. Pansky, E. Koehler, M. Bihl, M. Tamm, P. Hildebrand, A. P. Perruchoud, M. Kashgarian, and M. Roth. 2001. Molecular mechanisms of TGF-β antagonism by interferon γ and cyclosporine A in lung fibroblasts. FASEB J. 15:797.
34. Mochizuki, M., J. Bartels. A. I. Mallet, E. Christophers, and J. M. Schröder. 1998. IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J. Immunol. 160:60.
35. Teran, L. M., M. Mochizuki, J. Bartels, E. L. Valencia, T. Nakajima, K. Hirai, and J. M. Schroder. 1999. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 20:777.
36. Miyamasu, M., M. Yamaguchi, T. Nakajima, Y. Misaki, Y. Morita, K. Matsushima, K. Yamamoto, and K. Hirai. 1999. Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro. Int. Immunol. 11:1001.
37. Sato, E., D. K. Nelson, S. Koyama, J. C. Hoyt, and R. A. Robbins. 2001. Inflammatory cytokines modulate eotaxin release by human lung fibroblast cell line. Exp. Lung. Res. 27:173.
38. Huang, T. J., P. A. MacAry, T. Wilke, D. M. Kemeny, and K. F. Chung. 1999. Inhibitory effects of endogenous and exogenous interferon-γ on bronchial hyper-responsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats. Immunology 98:280.
39. Li, X.-M., R. K. Chopra, T.-Y. Chou, B. H, Schonfield, M. Wills-Karp, and S.-K. Huang. 1996. Mucosal IFN-T gene transfer inhibits pulmonary allergic responses in mice. J. Immunol. 157:3216.
40. Coyle, A. J., S. Tsuyuki, C. Bertrand, S. Huang, M. Aguet, S. S. Alkan, and G. P. Anderson. 1996. Mice lacking the IFN-γ receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 156:2680.
41. Noh, G. W., and K. Y. Lee. 1998. Blood eosinophils and serum IgE as predictors for prognosis of interferon-γ therapy in atopic dermatitis. Allergy 53:1202.
42. Musial, J., M. Milewski, A. Undas, P. Kopinski, M. Duplaga, and A. Szczeklik. 1995. Interferon-γ in the treatment of atopic dermatitis: Influence on T-cell activation. Allergy 50:5.
43. Lipkowitz, M. S., E. Leal-Pinto, J. Z. Rappoport, V. Najfeld, and R. G. Abramson. 2001. Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. J. Clin. Invest. 107:1103.